e-learning
resources
Amsterdam 2011
Monday, 26.09.2011
Highlights in the treatment of pleural empyema
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
New antibiotic and other medical options for treatment of non-tuberculous empyema according to its classification
F. Blasi (Milan, Italy)
Source:
Annual Congress 2011 - Highlights in the treatment of pleural empyema
Session:
Highlights in the treatment of pleural empyema
Session type:
Symposium
Number:
2915
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
F. Blasi (Milan, Italy). New antibiotic and other medical options for treatment of non-tuberculous empyema according to its classification. Annual Congress 2011 - Highlights in the treatment of pleural empyema
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Influence of adherence to clinical guidelines in empiric antibiotics choice on outcomes of community-acquired pneumonia in hospitalized Belarussian patients
Source: Eur Respir J 2005; 26: Suppl. 49, 637s
Year: 2005
Antibiotic therapy of community-acquired pneumonia in the hospital setting: national guidelines and real clinical practice.
Source: International Congress 2017 – COPD management
Year: 2017
Does standardized medical treatment for parapneumonic empyema (PE) in children reduces the need for surgical intervention?
Source: Annual Congress 2013 –Pulmonary infection in children: diagnosis and long-term effects
Year: 2013
New approaches to the aetiological diagnosis of VAP
Source: Eur Respir Mon 2011; 53: 11-23
Year: 2011
Surgical approach to multiresistant cavitary mycobacteriosis: indications and results of surgical management
Source: Annual Congress 2004 - PG11 - Multiresistant tuberculosis and atypical mycobacterial disease
Year: 2004
Antibiotic strategy in pleural empyema in children: research of a consensus by DELPHI method
Source: International Congress 2019 – Pleural infection and complicated pneumonia
Year: 2019
Adherence to guidelines' empirical antibiotic recommendations and community-acquired pneumonia outcome
Source: Eur Respir J 2008; 32: 892-901
Year: 2008
Community acquired pneumonia guidelines: not only treatment indications
Source: Annual Congress 2004 - PG22 - New perspectives in pneumonia treatment and prophylaxis
Year: 2004
New guidelines for treatment of nontuberculous mycobacterial pulmonary disease
Source: Virtual Congress 2020 – German programme 2020
Year: 2020
Can CAP guideline adherence improve patient outcome in internal medicine departments?
Source: Eur Respir J 2008; 32: 902-910
Year: 2008
Community-acquired pneumonia in pediatric patients: New diagnostic priorities
Source: Annual Congress 2012 - Asthma management
Year: 2012
International Guideline concordance of empiric antibiotic use in community-acquired pneumonia
Source: Virtual Congress 2020 – Antibiotic therapy for pneumonia and pleural infections
Year: 2020
Bacterial infections and indications for treatment with antibiotics in paediatric asthma?
Source: Annual Congress 2010 - High-priority questions on airway infections in diseases seen in children and adults
Year: 2010
Management of community-acquired pneumonia: new evidence-based algorithms.
Source: Virtual Congress 2021 – Emerging data for the management of respiratory tract infections
Year: 2021
Cost-effective antibiotic management of community acquired pneumonia
Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=198
Year: 2004
Verifying the antibiotic selection algorithm in the new Japanese pneumonia guidelines - Is algorithm-discordant treatment associated with increased mortality of healthcare-associated pneumonia?
Source: International Congress 2018 – Pneumonia: from the community to the intensive care unit
Year: 2018
The influence of modern microbiological methods on the antibiotic treatment of pneumonia in children
Source: International Congress 2018 – Paediatric respiratory infections: mechanistic insights and clinical outcomes
Year: 2018
Trends in empiric antimicrobial therapy and efficiency of care for community-acquired pneumonia in hospitalized Belarussian patients
Source: Annual Congress 2007 - Antibiotic treatment in community-acquired pneumonia
Year: 2007
Differences in clinical courses of nosocomial pneumonia between patients of surgical and therapeutic departments
Source: Eur Respir J 2006; 28: Suppl. 50, 787s
Year: 2006
The efficiency of surgical treatment for multidrug-resistant pulmonary and pleural tuberculosis
Source: International Congress 2016 – Surgical strategy for complex diseases
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept